Hong Kong’s oldest university plans to support the mass production of nuclear medicine in the city by setting up a production plant in the proposed Northern Metropolis megaproject to halve the cost as it aims to apply such treatment to more types of cancer.
University of Hong Kong (HKU) researchers aim to develop a new form of nuclear medicine to treat nasopharyngeal cancer, which has one of the world’s highest incidence rates in southern China, after achieving initial success with two other…